Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Doll

Showing results (381-390 of 436) with videos related to

Pageof 44
Sort By:
Journal of the American Heart Association|April 18, 2020
Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance ProgramsJacob A Doll, Lisa A Kaltenbach, Kevin J Anstrom, et al.
American Heart Journal|June 15, 2016
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarctionJacob A Doll, Tracy Y Wang, Niteesh K Choudhry, et al.
Journal of the American Heart Association|May 28, 2020
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment ProgramAkash Kataruka, Charles C Maynard, Kathleen E Kearney, et al.
Antioxidants (Basel, Switzerland)|July 2, 2021
Na/H Exchange Regulatory Factor 1 Deficient Mice Show Evidence of Oxidative Stress and Altered Cisplatin PharmacokineticsAdrienne M Bushau-Sprinkle, Michelle T Barati, Yuxuan Zheng, et al.
Journal of Lipid Research|February 13, 2022
Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injurySophia M Sears, Tess V Dupre, Parag P Shah, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2011
Mutations in SERPINF1 cause osteogenesis imperfecta type VIErica P Homan, Frank Rauch, Ingo Grafe, et al.
International Journal of Cancer|June 17, 2011
Hair dye use and risk of bladder cancer in the New England bladder cancer studyStella Koutros, Debra T Silverman, Dalsu Baris, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2007
Molecular determinants of invasion in endometrial cancerM Abal, M Llauradó, A Doll, et al.
Circulation. Cardiovascular Interventions|September 5, 2020
Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington StateAshwin S Nathan, Swathi Raman, Nancy Yang, et al.
Journal of the American College of Cardiology|February 27, 2016
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus ClopidogrelJacob A Doll, Megan L Neely, Matthew T Roe, et al.
Pageof 44

Showing results (381-390 of 436) with videos related to

Sort By:
Pageof 44
Journal of the American Heart Association|April 18, 2020
Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance ProgramsJacob A Doll, Lisa A Kaltenbach, Kevin J Anstrom, et al.
American Heart Journal|June 15, 2016
Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarctionJacob A Doll, Tracy Y Wang, Niteesh K Choudhry, et al.
Journal of the American Heart Association|May 28, 2020
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment ProgramAkash Kataruka, Charles C Maynard, Kathleen E Kearney, et al.
Antioxidants (Basel, Switzerland)|July 2, 2021
Na/H Exchange Regulatory Factor 1 Deficient Mice Show Evidence of Oxidative Stress and Altered Cisplatin PharmacokineticsAdrienne M Bushau-Sprinkle, Michelle T Barati, Yuxuan Zheng, et al.
Journal of Lipid Research|February 13, 2022
Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injurySophia M Sears, Tess V Dupre, Parag P Shah, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 10, 2011
Mutations in SERPINF1 cause osteogenesis imperfecta type VIErica P Homan, Frank Rauch, Ingo Grafe, et al.
International Journal of Cancer|June 17, 2011
Hair dye use and risk of bladder cancer in the New England bladder cancer studyStella Koutros, Debra T Silverman, Dalsu Baris, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 26, 2007
Molecular determinants of invasion in endometrial cancerM Abal, M Llauradó, A Doll, et al.
Circulation. Cardiovascular Interventions|September 5, 2020
Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington StateAshwin S Nathan, Swathi Raman, Nancy Yang, et al.
Journal of the American College of Cardiology|February 27, 2016
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus ClopidogrelJacob A Doll, Megan L Neely, Matthew T Roe, et al.
Pageof 44